Related Experiment Video
Updated: Jun 20, 2026
08:15
In Vitro Cellular Activity Evaluation of the Nanoemulsion Vaccine Adjuvant Ophiopogonin D
Published on: December 9, 2022
Immunosuppressive withanolides from Withania coagulans.
Chao-Feng Huang1, Lei Ma, Li-Juan Sun
1Shanghai Research Center for Modernization of Traditional Chinese Medicine, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 199 Guoshoujing Road, Shanghai 201203, P. R. China.
Chemistry & Biodiversity
|September 24, 2009
Summary
Six new compounds from Withania coagulans, called withacoagulins A-F, were identified. These compounds, along with others from the plant, show strong inhibitory effects on T- and B-cell proliferation.
Area of Science:
- Phytochemistry
- Immunology
- Natural Products Chemistry
Background:
- Withania coagulans is a medicinal plant known for its therapeutic properties.
- Withanolides are a class of steroidal lactones with diverse biological activities.
- Understanding the chemical constituents and immunological effects of W. coagulans is crucial for its medicinal applications.
Purpose of the Study:
- To isolate and characterize new withanolides from the aerial parts of Withania coagulans.
- To evaluate the immunomodulatory potential of isolated compounds and crude extracts.
- To investigate the inhibitory effects on T- and B-cell proliferation.
Main Methods:
- Isolation of compounds using chromatographic techniques.
- Structure elucidation using 1D and 2D Nuclear Magnetic Resonance (NMR) spectroscopy (1H, 13C, HMQC, HMBC) and Mass Spectrometry (MS).
- In vitro assessment of T- and B-cell proliferation inhibition.
Main Results:
- Six new withanolides, designated withacoagulins A-F (1-6), were successfully isolated.
- Ten known withanolides (7-16) were also identified in the same extract.
- Both the isolated compounds and the crude extracts of Withania coagulans demonstrated significant inhibitory activity against T- and B-cell proliferation.
Conclusions:
- The study successfully identified novel withanolides from Withania coagulans.
- The findings highlight the potent immunomodulatory effects of these compounds, particularly their ability to inhibit lymphocyte proliferation.
- This research contributes to the understanding of the pharmacological basis of Withania coagulans' traditional uses and suggests potential therapeutic applications in immune-related conditions.
Related Concept Videos
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:15Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
01:15Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.